articles & publications

 Mar 20, 2019

"NCORP Tissue Procurement Protocol to Open at 12 Community Sites was originally published by the National Cancer Institute"

At 12 NCI Community Oncology Research Program (NCORP) sites across the United States, a new kind of study will soon be opening for patients with advanced malignancies being treated with molecularly targeted therapies. The NCORP Tissue Procurement Protocol (NCI 10231, NCT 03707574) is not a treatment trial, but a study to assess if researchers can obtain tissue and blood samples at baseline and upon progression in patients with advanced cancer being treated with molecularly targeted therapies — and to see if analysis of those samples will shed light on why cancer cells stop responding to treatment and what can be done when this happens.

 Mar 20, 2019

TMIST PI Pisano: “Are we further reducing breast cancer mortality the more intensively we screen? was originally published by The Cancer Letter Inc"

The Tomosynthesis Mammographic Imaging Screening Trial, a massive randomized trial of early detection, is asking an important question: Is digital breast tomosynthesis better than digital mammography in reducing development of advanced breast cancer?

 Nov 01, 2015

Bringing Cutting-Edge Cancer Care Across Georgia; Georgia NCORP Spearheads Statewide Research Collaboration

A statewide initiative involving multiple hospitals and healthcare organizations is poised to bring the latest in cancer research and care to communities throughout the state of Georgia. This unprecedented partnership, sponsored by Northside Hospital Cancer Institute, was selected by the National Cancer Institute (NCI) as a NCI Community Oncology Research Program (NCORP). The designation includes a five-year, $5.85-million grant.